The Neuromodulation Market to grow at a CAGR of 12.02% from 2022 to 2027; The expanding applications of neuromodulation therapies is a major trend- Technavio

NEW YORK, Aug. 9, 2023 /PRNewswire/ -- The neuromodulation market is projected to progress at a CAGR of 12.02 % between 2022 and 2027, the size of the market is forecast to increase by USD 5,332.29 million during the forecast period. The expanding applications of neuromodulation therapies is a major trend in the market. The use of neuromodulation therapies is being researched for a growing number of applications outside of their current indications. Transcranial magnetic stimulation (TMS) and transcranial direct current stimulation are two neuromodulation treatments being researched for their potential use in the rehabilitation of stroke victims. Additionally, these treatments are intended to lessen brain activity and promote neuroplasticity, promoting both motor recovery and functional improvement after a stroke. Neuromodulation therapies aim to control neural activity and lessen cravings by focusing on brain areas associated with addiction pathways, assisting people in overcoming substance usage and addictive behaviors. Hence, these factors are expected to drive market growth during the forecast period. For further information on Market growth and size -Request a sample report

Neuromodulation Market – Market Dynamics

Key Driver

The increasing awareness of initiatives and access to healthcare is a key factor driving market growth. Numerous governmental and commercial organizations are working to increase understanding of neurological illnesses and sufferers' access to healthcare. The World Health Organization (WHO) is collaborating with various partners and stakeholders to increase epilepsy patients' access to healthcare. The International Neuromodulation Society is a nonprofit organization devoted to the advancement of neuromodulation science and public knowledge of it. Through meetings, peer-reviewed papers, illuminating content, and chapter websites, it also disseminates information and advances the neuromodulation discipline. Additionally, companies like LivaNova are making efforts to raise awareness of neurological illnesses. The number of governmental and commercial organizations financing research projects to learn more about the physiology of neurological illnesses is growing.

For instance, to increase the advancement of neuroscience research, Abbott Laboratories and NIH collaborated on the BRAIN initiative. In accordance with the terms of the agreement, Abbott Laboratories will contribute its neuromodulation technologies, such as directional DBS, SCS, and dorsal root ganglion (DRG) therapies, to studies pertaining to these NIH initiatives to investigate their potential applications in the treatment of persistent pain and progressive movement disorders, such as Parkinson's disease (PD). Hence, the above-mentioned factors are expected to drive market growth during the forecast period.

Further information on drivers  – Request a sample report

Other Key Data Covered in Neuromodulation market report- 

• Detailed information on factors, including driver details 
• Market segmentation by Product (Implantable neuromodulation devices and External neuromodulation devices), End-user (Hospitals, ASCs, and Others), and Geography (North America, Europe, Asia, and Rest of World (ROW)) 
• Precise estimation of the neuromodulation market size and its contribution to the parent market
• Accurate predictions about upcoming trends and changes in consumer behavior
• Comprehensive analysis of factors that will challenge the growth of crowdfunding market companies
• A thorough analysis of the market's competitive landscape and detailed information about companies
• Growth of the industry across APAC, North America, Europe, Middle East and Africa, and South America
• CAGR of the market during the forecast period

Download Sample Report to get an overview of market size, comparing historic market values with future estimates, analysis of segmentation, current market dynamics, competitive intelligence with key developments and growth strategies of major players

Neuromodulation Market - Company Analysis and Scope

Some of the major companies in the data center cooling solutions market are Abbott Laboratories, Axonics Inc., BioWave Ltd., Boston Scientific Corp., BrainsWay Ltd., Cognito Therapeutics, electroCore Inc., Evren Technologies Inc., LivaNova Plc, Medtronic Plc, NeuroMetrix Inc., NEURONETICS Inc., Nevro Corp., OMRON Corp., PathMaker Neurosystems Inc., Saluda Medical Pty Ltd., ShiraTronics, Theranica Bio Electronics Ltd., Thync Global Inc., and Ziv HealthCare Ltd.

Company Offerings

• Abbott Laboratories, Axonics Inc. - The company offers neuromodulation such as neurostimulation devices for pain management and neurological disorders.
• Axonics Inc. - The company offers neuromodulation such as sacral neuromodulation systems for bladder and bowel control.
• Medtronic Plc - The company offers neuromodulation such as deep brain stimulation systems and spinal cord stimulation for neurological disorders.

What's New? -

• Special coverage on the Russia-Ukraine war; global inflation; recovery analysis from COVID-19; supply chain disruptions, global trade tensions; and risk of recession
• Global competitiveness and key competitor positions
• Market presence across multiple geographical footprints - Strong/Active/Niche/Trivial - Buy the report!

Gain instant access to 17,000+ market research reports. 

Technavio's SUBSCRIPTION platform

Related Reports

The aesthetic lasers and energy devices market is estimated to grow by USD 1,910.58 million at a CAGR of 9.73% between 2022 and 2027. Furthermore, this report extensively covers market segmentation by technology (laser, light, RF, and others), application (skin resurfacing, body contouring, and skin rejuvenation, and geography (North America, Europe, Asia, and the Rest of the World (ROW)). Opportunities for growth in male aesthetics are a major trend in the market.

The electroencephalography (EEG) electrodes market is estimated to grow by USD 104.27 million, at a CAGR of 7.08% between 2022 and 2027. geography (North America, Europe, Asia, and the Rest of the World (ROW), product (disposable EEG electrodes and reusable EEG electrodes), and end-User (hospitals, clinics, and others). The rising popularity of hybrid brain-computer interface techniques is a major trend in the market.

Table of Contents

1 Executive Summary

• 1.1 Market Overview
• Exhibit 01: Executive Summary – Chart on Market Overview
• Exhibit 02: Executive Summary – Data Table on Market Overview
• Exhibit 03: Executive Summary – Chart on Global Market Characteristics
• Exhibit 04: Executive Summary – Chart on Market by Geography
• Exhibit 05: Executive Summary – Chart on Market Segmentation by Product
• Exhibit 06: Executive Summary – Chart on Market Segmentation by End-user
• Exhibit 07: Executive Summary – Chart on Incremental Growth
• Exhibit 08: Executive Summary – Data Table on Incremental Growth
• Exhibit 09: Executive Summary – Chart on Company Market Positioning

2 Market Landscape

• 2.1 Market ecosystem
• Exhibit 10: Parent market
• Exhibit 11: Market Characteristics

3 Market Sizing

• 3.1 Market definition
• Exhibit 12: Offerings of companies included in the market definition

• 3.2 Market segment analysis 
• Exhibit 13: Market segments

• 3.3 Market size 2022

• 3.4 Market outlook: Forecast for 2022-2027 
• Exhibit 14: Chart on Global - Market size and forecast 2022-2027 ($ million)
• Exhibit 15: Data Table on Global - Market size and forecast 2022-2027 ($ million)
• Exhibit 16: Chart on Global Market: Year-over-year growth 2022-2027 (%)
• Exhibit 17: Data Table on Global Market: Year-over-year growth 2022-2027 (%)

4 Historic Market Size

• 4.1 Global neuromodulation market 2017 - 2021 
• Exhibit 18: Historic Market Size – Data Table on global neuromodulation market 2017 - 2021 ($ million)

• 4.2 Product Segment Analysis 2017 - 2021 
• Exhibit 19: Historic Market Size – Product Segment 2017 - 2021 ($ million)

• 4.3 End-user Segment Analysis 2017 - 2021 
• Exhibit 20: Historic Market Size – End-user Segment 2017 - 2021 ($ million)

• 4.4 Geography Segment Analysis 2017 - 2021 
• Exhibit 21: Historic Market Size – Geography Segment 2017 - 2021 ($ million)

• 4.5 Country Segment Analysis 2017 - 2021 
• Exhibit 22: Historic Market Size – Country Segment 2017 - 2021 ($ million)

5 Five Forces Analysis

• 5.1 Five forces summary
• Exhibit 23: Five forces analysis - Comparison between 2022 and 2027

• 5.2 Bargaining power of buyers 
• Exhibit 24: Chart on Bargaining power of buyers – Impact of key factors 2022 and 2027

• 5.3 Bargaining power of suppliers 
• Exhibit 25: Bargaining power of suppliers – Impact of key factors in 2022 and 2027

• 5.4 Threat of new entrants 
• Exhibit 26: Threat of new entrants – Impact of key factors in 2022 and 2027

• 5.5 Threat of substitutes 
• Exhibit 27: Threat of substitutes – Impact of key factors in 2022 and 2027

• 5.6 Threat of rivalry
• Exhibit 28: Threat of rivalry – Impact of key factors in 2022 and 2027

• 5.7 Market condition
• Exhibit 29: Chart on Market condition - Five forces 2022 and 2027

6 Market Segmentation by Product

• 6.1 Market segments
• Exhibit 30: Chart on Product - Market share 2022-2027 (%)
• Exhibit 31: Data Table on Product - Market share 2022-2027 (%)

• 6.2 Comparison by Product 
• Exhibit 32: Chart on Comparison by Product
• Exhibit 33: Data Table on Comparison by Product

• 6.3 Implantable neuromodulation devices - Market size and forecast 2022-2027 
• Exhibit 34: Chart on Implantable neuromodulation devices - Market size and forecast 2022-2027 ($ million)
• Exhibit 35: Data Table on Implantable neuromodulation devices - Market size and forecast 2022-2027 ($ million)
• Exhibit 36: Chart on Implantable neuromodulation devices - Year-over-year growth 2022-2027 (%)
• Exhibit 37: Data Table on Implantable neuromodulation devices - Year-over-year growth 2022-2027 (%)

• 6.4 External neuromodulation devices - Market size and forecast 2022-2027 
• Exhibit 38: Chart on External neuromodulation devices - Market size and forecast 2022-2027 ($ million)
• Exhibit 39: Data Table on External neuromodulation devices - Market size and forecast 2022-2027 ($ million)
• Exhibit 40: Chart on External neuromodulation devices - Year-over-year growth 2022-2027 (%)
• Exhibit 41: Data Table on External neuromodulation devices - Year-over-year growth 2022-2027 (%)

• 6.5 Market opportunity by Product 
• Exhibit 42: Market opportunity by Product ($ million)
• Exhibit 43: Data Table on Market opportunity by Product ($ million)

7 Market Segmentation by End-user

• 7.1 Market segments
• Exhibit 44: Chart on End-user - Market share 2022-2027 (%)
• Exhibit 45: Data Table on End-user - Market share 2022-2027 (%)

• 7.2 Comparison by End-user 
• Exhibit 46: Chart on Comparison by End-user
• Exhibit 47: Data Table on Comparison by End-user

• 7.3 Hospitals - Market size and forecast 2022-2027 
• Exhibit 48: Chart on Hospitals - Market size and forecast 2022-2027 ($ million)
• Exhibit 49: Data Table on Hospitals - Market size and forecast 2022-2027 ($ million)
• Exhibit 50: Chart on Hospitals - Year-over-year growth 2022-2027 (%)
• Exhibit 51: Data Table on Hospitals - Year-over-year growth 2022-2027 (%)

• 7.4 ASCs - Market size and forecast 2022-2027 
• Exhibit 52: Chart on ASCs - Market size and forecast 2022-2027 ($ million)
• Exhibit 53: Data Table on ASCs - Market size and forecast 2022-2027 ($ million)
• Exhibit 54: Chart on ASCs - Year-over-year growth 2022-2027 (%)
• Exhibit 55: Data Table on ASCs - Year-over-year growth 2022-2027 (%)

• 7.5 Others - Market size and forecast 2022-2027 
• Exhibit 56: Chart on Others - Market size and forecast 2022-2027 ($ million)
• Exhibit 57: Data Table on Others - Market size and forecast 2022-2027 ($ million)
• Exhibit 58: Chart on Others - Year-over-year growth 2022-2027 (%)
• Exhibit 59: Data Table on Others - Year-over-year growth 2022-2027 (%)

• 7.6 Market opportunity by End-user 
• Exhibit 60: Market opportunity by End-user ($ million)
• Exhibit 61: Data Table on Market opportunity by End-user ($ million)

8 Customer Landscape

• 8.1 Customer landscape overview 
• Exhibit 62: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria

9 Geographic Landscape

• 9.1 Geographic segmentation 
• Exhibit 63: Chart on Market share by geography 2022-2027 (%)
• Exhibit 64: Data Table on Market share by geography 2022-2027 (%)

• 9.2 Geographic comparison 
• Exhibit 65: Chart on Geographic comparison
• Exhibit 66: Data Table on Geographic comparison

• 9.3 North America - Market size and forecast 2022-2027 
• Exhibit 67: Chart on North America - Market size and forecast 2022-2027 ($ million)
• Exhibit 68: Data Table on North America - Market size and forecast 2022-2027 ($ million)
• Exhibit 69: Chart on North America - Year-over-year growth 2022-2027 (%)
• Exhibit 70: Data Table on North America - Year-over-year growth 2022-2027 (%)

• 9.4 Europe - Market size and forecast 2022-2027 
• Exhibit 71: Chart on Europe - Market size and forecast 2022-2027 ($ million)
• Exhibit 72: Data Table on Europe - Market size and forecast 2022-2027 ($ million)
• Exhibit 73: Chart on Europe - Year-over-year growth 2022-2027 (%)
• Exhibit 74: Data Table on Europe - Year-over-year growth 2022-2027 (%)

• 9.5 Asia - Market size and forecast 2022-2027 
• Exhibit 75: Chart on Asia - Market size and forecast 2022-2027 ($ million)
• Exhibit 76: Data Table on Asia - Market size and forecast 2022-2027 ($ million)
• Exhibit 77: Chart on Asia - Year-over-year growth 2022-2027 (%)
• Exhibit 78: Data Table on Asia - Year-over-year growth 2022-2027 (%)

• 9.6 Rest of World (ROW) - Market size and forecast 2022-2027 
• Exhibit 79: Chart on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million)
• Exhibit 80: Data Table on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million)
• Exhibit 81: Chart on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
• Exhibit 82: Data Table on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)

• 9.7 US - Market size and forecast 2022-2027 
• Exhibit 83: Chart on US - Market size and forecast 2022-2027 ($ million)
• Exhibit 84: Data Table on US - Market size and forecast 2022-2027 ($ million)
• Exhibit 85: Chart on US - Year-over-year growth 2022-2027 (%)
• Exhibit 86: Data Table on US - Year-over-year growth 2022-2027 (%)

• 9.8 Germany - Market size and forecast 2022-2027 
• Exhibit 87: Chart on Germany - Market size and forecast 2022-2027 ($ million)
• Exhibit 88: Data Table on Germany - Market size and forecast 2022-2027 ($ million)
• Exhibit 89: Chart on Germany - Year-over-year growth 2022-2027 (%)
• Exhibit 90: Data Table on Germany - Year-over-year growth 2022-2027 (%)

• 9.9 UK - Market size and forecast 2022-2027 
• Exhibit 91: Chart on UK - Market size and forecast 2022-2027 ($ million)
• Exhibit 92: Data Table on UK - Market size and forecast 2022-2027 ($ million)
• Exhibit 93: Chart on UK - Year-over-year growth 2022-2027 (%)
• Exhibit 94: Data Table on UK - Year-over-year growth 2022-2027 (%)

• 9.10 Japan - Market size and forecast 2022-2027 
• Exhibit 95: Chart on Japan - Market size and forecast 2022-2027 ($ million)
• Exhibit 96: Data Table on Japan - Market size and forecast 2022-2027 ($ million)
• Exhibit 97: Chart on Japan - Year-over-year growth 2022-2027 (%)
• Exhibit 98: Data Table on Japan - Year-over-year growth 2022-2027 (%)

• 9.11 China - Market size and forecast 2022-2027 
• Exhibit 99: Chart on China - Market size and forecast 2022-2027 ($ million)
• Exhibit 100: Data Table on China - Market size and forecast 2022-2027 ($ million)
• Exhibit 101: Chart on China - Year-over-year growth 2022-2027 (%)
• Exhibit 102: Data Table on China - Year-over-year growth 2022-2027 (%)

• 9.12 Market opportunity by geography 
• Exhibit 103: Market opportunity by geography ($ million)
• Exhibit 104: Data Tables on Market opportunity by geography ($ million)

10 Drivers, Challenges, and Trends

• 10.1 Market drivers

• 10.2 Market challenges

• 10.3 Impact of drivers and challenges 
• Exhibit 105: Impact of drivers and challenges in 2022 and 2027

• 10.4 Market trends

11 Company Landscape

• 11.1 Overview

• 11.2 Company landscape
• Exhibit 106: Overview on Criticality of inputs and Factors of differentiation

• 11.3 Landscape disruption
• Exhibit 107: Overview on factors of disruption

• 11.4 Industry risks
• Exhibit 108: Impact of key risks on business

12 Company Analysis

• 12.1 Companies covered
• Exhibit 109: Companies covered

• 12.2 Market positioning of companies 
• Exhibit 110: Matrix on company position and classification

• 12.3 Abbott Laboratories
• Exhibit 111: Abbott Laboratories - Overview
• Exhibit 112: Abbott Laboratories - Business segments
• Exhibit 113: Abbott Laboratories - Key news
• Exhibit 114: Abbott Laboratories - Key offerings
• Exhibit 115: Abbott Laboratories - Segment focus

• 12.4 Axonics Inc.
• Exhibit 116: Axonics Inc. - Overview
• Exhibit 117: Axonics Inc. - Business segments
• Exhibit 118: Axonics Inc. - Key offerings
• Exhibit 119: Axonics Inc. - Segment focus

• 12.5 Boston Scientific Corp. 
• Exhibit 120: Boston Scientific Corp. - Overview
• Exhibit 121: Boston Scientific Corp. - Business segments
• Exhibit 122: Boston Scientific Corp. - Key news
• Exhibit 123: Boston Scientific Corp. - Key offerings
• Exhibit 124: Boston Scientific Corp. - Segment focus

• 12.6 BrainsWay Ltd.
• Exhibit 125: BrainsWay Ltd. - Overview
• Exhibit 126: BrainsWay Ltd. - Product / Service
• Exhibit 127: BrainsWay Ltd. - Key offerings

• 12.7 electroCore Inc.
• Exhibit 128: electroCore Inc. - Overview
• Exhibit 129: electroCore Inc. - Product / Service
• Exhibit 130: electroCore Inc. - Key offerings

• 12.8 LivaNova Plc
• Exhibit 131: LivaNova Plc - Overview
• Exhibit 132: LivaNova Plc - Business segments
• Exhibit 133: LivaNova Plc - Key offerings
• Exhibit 134: LivaNova Plc - Segment focus

• 12.9 Medtronic Plc
• Exhibit 135: Medtronic Plc - Overview
• Exhibit 136: Medtronic Plc - Business segments
• Exhibit 137: Medtronic Plc - Key news
• Exhibit 138: Medtronic Plc - Key offerings
• Exhibit 139: Medtronic Plc - Segment focus

• 12.10 NeuroMetrix Inc.
• Exhibit 140: NeuroMetrix Inc. - Overview
• Exhibit 141: NeuroMetrix Inc. - Product / Service
• Exhibit 142: NeuroMetrix Inc. - Key offerings

• 12.11 NEURONETICS Inc.
• Exhibit 143: NEURONETICS Inc. - Overview
• Exhibit 144: NEURONETICS Inc. - Product / Service
• Exhibit 145: NEURONETICS Inc. - Key offerings

• 12.12 Nevro Corp.
• Exhibit 146: Nevro Corp. - Overview
• Exhibit 147: Nevro Corp. - Product / Service
• Exhibit 148: Nevro Corp. - Key offerings

• 12.13 OMRON Corp.
• Exhibit 149: OMRON Corp. - Overview
• Exhibit 150: OMRON Corp. - Business segments
• Exhibit 151: OMRON Corp. - Key news
• Exhibit 152: OMRON Corp. - Key offerings
• Exhibit 153: OMRON Corp. - Segment focus

• 12.14 PathMaker Neurosystems Inc. 
• Exhibit 154: PathMaker Neurosystems Inc. - Overview
• Exhibit 155: PathMaker Neurosystems Inc. - Product / Service
• Exhibit 156: PathMaker Neurosystems Inc. - Key offerings

• 12.15 Saluda Medical Pty Ltd. 
• Exhibit 157: Saluda Medical Pty Ltd. - Overview
• Exhibit 158: Saluda Medical Pty Ltd. - Product / Service
• Exhibit 159: Saluda Medical Pty Ltd. - Key offerings

• 12.16 ShiraTronics
• Exhibit 160: ShiraTronics - Overview
• Exhibit 161: ShiraTronics - Product / Service
• Exhibit 162: ShiraTronics - Key offerings

• 12.17 Theranica Bio Electronics Ltd. 
• Exhibit 163: Theranica Bio Electronics Ltd. - Overview
• Exhibit 164: Theranica Bio Electronics Ltd. - Product / Service
• Exhibit 165: Theranica Bio Electronics Ltd. - Key offerings

13 Appendix

• 13.1 Scope of the report

• 13.2 Inclusions and exclusions checklist 
• Exhibit 166: Inclusions checklist
• Exhibit 167: Exclusions checklist

• 13.3 Currency conversion rates for US$ 
• Exhibit 168: Currency conversion rates for US$

• 13.4 Research methodology
• Exhibit 169: Research methodology
• Exhibit 170: Validation techniques employed for market sizing
• Exhibit 171: Information sources

• 13.5 List of abbreviations
• Exhibit 172: List of abbreviations

About Us
Technavio is a leading global technology research and advisory company. Their research and analysis focus on emerging market trends and provides actionable insights to help businesses identify market opportunities and develop effective strategies to optimize their market positions. With over 500 specialized analysts, Technavio's report library consists of more than 17,000 reports and counting, covering 800 technologies, spanning across 50 countries. Their client base consists of enterprises of all sizes, including more than 100 Fortune 500 companies. This growing client base relies on Technavio's comprehensive coverage, extensive research, and actionable market insights to identify opportunities in existing and potential markets and assess their competitive positions within changing market scenarios.

Contact
Technavio Research
Jesse Maida
Media & Marketing Executive
US: +1 844 364 1100
UK: +44 203 893 3200
Email: [email protected]
Website: www.technavio.com

SOURCE Technavio